Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Joseph A Boscarino, Carrie A Withey, Ryan J Dugan, Yirui Hu, Jessica Auciello & Thomas Alfieri. (2020) Opioid Medication Use Among Chronic Non-Cancer Pain Patients Assessed with a Modified Drug Effects Questionnaire and the Association with Opioid Use Disorder. Journal of Pain Research 13, pages 2697-2705.
Read now
Read now
Harvey L. Nicholson$suffix/text()$suffix/text(). (2020) Socioeconomic status, fundamental cause theory, and prescription opioid use behaviors: a theoretical examination. Sociological Spectrum 40:1, pages 1-32.
Read now
Read now
Paul M. Coplan, M. Soledad Cepeda, Kenneth R. Petronis, Angela DeVeaugh-Geiss, Alexandra I. Barsdorf, David M. Kern & Richard Fanelli. (2020) Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patients. Postgraduate Medicine 132:1, pages 44-51.
Read now
Read now
Pol Bruguera, Pablo Barrio, Lluïsa Ortega, Ana Isabel Lopez-Lazcano, Adela Fauli & Anna Lligoña. (2018) Heavy prescription over time leading to opioid dependence. Journal of Substance Use 23:6, pages 579-583.
Read now
Read now
Tauheed Zaman, Tessa L. Rife, Steven L. Batki & David L. Pennington. (2018) An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines. Substance Abuse 39:4, pages 441-448.
Read now
Read now
Junie S Carriere, Marc-Olivier Martel, Ming-Chih Kao, Michael JL Sullivan & Beth D Darnall. (2017) Pain behavior mediates the relationship between perceived injustice and opioid prescription for chronic pain: a Collaborative Health Outcomes Information Registry study. Journal of Pain Research 10, pages 557-566.
Read now
Read now
Joseph A Boscarino, H Lester Kirchner, James M Pitcavage, Vijay R Nadipelli, Naoko A Ronquest, Michael H Fitzpatrick & John J Han. (2016) Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system. Substance Abuse and Rehabilitation 7, pages 131-141.
Read now
Read now
Martin D. Cheatle. (2016) Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities. Expert Review of Clinical Pharmacology 9:6, pages 751-754.
Read now
Read now
Articles from other publishers (53)
Ainhoa Coloma-Carmona & José Luis Carballo. (2023) Assessing Opioid Abuse in Chronic Pain Patients: Further Validation of the Prescription Opioid Misuse Index (POMI) Using Item Response Theory. International Journal of Mental Health and Addiction.
Crossref
Crossref
Philip J. FredaJrJr, Henry R. Kranzler & Jason H. Moore. (2022) Novel digital approaches to the assessment of problematic opioid use. BioData Mining 15:1.
Crossref
Crossref
Mark A. Strand, Heidi N. Eukel, Oliver Frenzel, Elizabeth Skoy, Jayme Steig & Amy Werremeyer. (2022) Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk Tool. Research in Social and Administrative Pharmacy 18:12, pages 4065-4071.
Crossref
Crossref
R. Lynae Roberts & Eric L. Garland. (2022) Association between opioid use disorder and blunted heart rate variability among opioid‐treated chronic pain patients. Addiction Biology 27:6.
Crossref
Crossref
Deborah S. HasinDvora ShmulewitzMalka StohlEliana GreensteinEfrat AharonovichKenneth R. PetronisMichael Von KorffSamyadev DattaNomita SontyStephen RossCharles InturrisiMichael L. WeinbergerJennifer ScodesMelanie M. Wall. (2022) Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain. American Journal of Psychiatry 179:10, pages 715-725.
Crossref
Crossref
Sara Rodríguez-Espinosa, Ainhoa Coloma-Carmona, Ana Pérez-Carbonell, José F. Román-Quiles & José L. Carballo. (2022) Differential Experience of Interdose Withdrawal During Long-Term Opioid Therapy and its Association With Patient and Treatment Characteristics: A Latent Class Analysis in Chronic Pain Population. The Journal of Pain 23:8, pages 1427-1436.
Crossref
Crossref
Elizabeth C.S. Swart, Terri V. Newman, Yan Huang, Robert J. Howell, Mei Han, Chester B. Good, Samuel K. Peasah & Natasha Parekh. (2022) Patient and medication‐related factors associated with opioid use disorder after inpatient opioid administration. Journal of Hospital Medicine 17:5, pages 342-349.
Crossref
Crossref
Tetsuya SAKAI. (2022) Risk Factors for Opioid Dependence - Things We Should Learn from the United States of America -オピオイド依存のリスクファクター─依存大国から学ぶべきこと─. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 42:2, pages 193-201.
Crossref
Crossref
Jarratt D. Pytell, Michael D. Sklar, Joseph Carrese, Darius A. Rastegar, Christine Gunn & Geetanjali Chander. (2021) “I’m a Survivor”: Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder. Journal of General Internal Medicine 37:3, pages 593-600.
Crossref
Crossref
ShabeerAli Thorakkattil, Gopika Krishnan, SaveraIkram Arain, MohammedSalim Karattuthodi, MamdouhMohammed Ahmed Ageeli, Sarath Chandran & Suhaj Abdulsalim. (2022) The necessity of implementing steroid stewardship: Are we lagging behind antimicrobials and opioids?. Saudi Journal of Clinical Pharmacy 1:4, pages 107.
Crossref
Crossref
Vanessa Troiani, Richard C. Crist, Glenn A. Doyle, Thomas N. Ferraro, Donielle Beiler, Stephanie Ranck, Kortney McBryan, Margaret A. Jarvis, Jordan S. Barbour, John J. Han, Ryan J. Ness, Wade H. Berrettini & Janet D. Robishaw. (2021) Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse. BMC Medical Genomics 14:1.
Crossref
Crossref
Pauline Voon, Jin Cheol Choi, Kanna Hayashi, M-J Milloy, Jane Buxton & Thomas Kerr. (2021) The effect of depressive symptoms on pain in a substance-using population with persistent pain: a cross-sectional cohort study. BMC Psychiatry 21:1.
Crossref
Crossref
Sara Rodríguez-Espinosa, Ainhoa Coloma-Carmona, Ana Pérez-Carbonell, José F. Román-Quiles & José L. Carballo. (2021) Clinical and psychological factors associated with interdose opioid withdrawal in chronic pain population. Journal of Substance Abuse Treatment 129, pages 108386.
Crossref
Crossref
Victoria D. Powell, Jack M. Rosenberg, Avani Yaganti, Claire Garpestad, Pooja Lagisetty, Carol Shannon & Maria J. Silveira. (2021) Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain. JAMA Network Open 4:9, pages e2124152.
Crossref
Crossref
Stephen E. Nadeau, Jeffrey K. Wu & Richard A. Lawhern. (2021) Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence. Frontiers in Pain Research 2.
Crossref
Crossref
Mark K. Greenwald, Tabitha E.H. Moses & Timothy A. Roehrs. (2021) At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities. Translational Research 234, pages 58-73.
Crossref
Crossref
Marc O. Martel, Alice Bruneau & Robert R. Edwards. (2021) Mind-body approaches targeting the psychological aspects of opioid use problems in patients with chronic pain: evidence and opportunities. Translational Research 234, pages 114-128.
Crossref
Crossref
Philip J. Freda, Jason H. Moore & Henry R. Kranzler. (2021) The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. Drug and Alcohol Dependence 221, pages 108602.
Crossref
Crossref
Nicholas Papadomanolakis-Pakis, Kieran M. Moore, Yingwei Peng & Tara Gomes. (2021) Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study. Drug and Alcohol Dependence 221, pages 108601.
Crossref
Crossref
Pooja Lagisetty, Claire Garpestad, Angela Larkin, Colin Macleod, Derek Antoku, Stephanie Slat, Jennifer Thomas, Victoria Powell, Amy S.B. Bohnert & Lewei A. Lin. (2021) Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence 221, pages 108583.
Crossref
Crossref
Yun Shen, Hemita Bhagwandass, Tychell Branchcomb, Sophia A. Galvez, Ivanna Grande, Julia Lessing, Mikela Mollanazar, Natalie Ourhaan, Razanne Oueini, Michael Sasser, Ivelisse L. Valdes, Ashmita Jadubans, Josef Hollmann, Michael Maguire, Silken Usmani, Scott M Vouri, Juan M Hincapie-Castillo, Lauren E. Adkins & Amie J Goodin. (2021) Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions. The Journal of Pain 22:3, pages 246-262.
Crossref
Crossref
Morgane Guillou-Landreat, Bertrand Quinio, Jean Yves Le Reste, Delphine Le Goff, Jérôme Fonsecca, Marie Grall-Bronnec & Antoine Dany. (2021) Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France. International Journal of Environmental Research and Public Health 18:4, pages 2097.
Crossref
Crossref
Tessa Rife, Christina Tat & Mahsa Malakootian. (2021) Evaluation of an opioid risk mitigation initiative for veterans undergoing hip or knee arthroplasty at San Francisco Veterans Affairs Health Care System. American Journal of Health-System Pharmacy 78:4, pages 336-344.
Crossref
Crossref
Johannes M. Just, Norbert Scherbaum, Michael Specka, Marie-Therese Puth & Klaus Weckbecker. (2020) Rate of opioid use disorder in adults who received prescription opioid pain therapy—A secondary data analysis. PLOS ONE 15:7, pages e0236268.
Crossref
Crossref
Pooja Lagisetty, Alex Smith, Derek Antoku, Suzanne Winter, Michael Smith, Mary Jannausch, Hae Mi Choe, Amy S B Bohnert & Michele Heisler. (2020) A physician-pharmacist collaborative care model to prevent opioid misuse. American Journal of Health-System Pharmacy 77:10, pages 771-780.
Crossref
Crossref
Robert E. Davis, Martha A. Bass, M. Allison Wade & Vinayak K. Nahar. (2020) Screening for depression among a sample of US college students who engage in recreational prescription opioid misuse. Health Promotion Perspectives 10:1, pages 59-65.
Crossref
Crossref
Paul J. Christo. (2021) Opioids May be Appropriate for Chronic Pain. Journal of Law, Medicine & Ethics 48:2, pages 241-248.
Crossref
Crossref
Gholam R. Kheirabadi, Sharyar Moazeni, Mehrdad Salehi & Behzad Mahaki. (2019) Pregabalin Does Not Reduce Opioid Withdrawal Symptoms: A Randomized Controlled Trial. Addictive Disorders & Their Treatment 18:4, pages 205-211.
Crossref
Crossref
Fatemeh Ayoobi, Reza Bidaki, Ali Shamsizadeh, Amir Moghadam-Ahmadi & Houshang Amiri. (2019) Impact of opium dependency on clinical and neuropsychological indices of multiple sclerosis patients. Neurological Sciences 40:12, pages 2501-2507.
Crossref
Crossref
Eric L. Garland, Sarah E. Reese, Carter E. Bedford & Anne K. Baker. (2019) Adverse childhood experiences predict autonomic indices of emotion dysregulation and negative emotional cue-elicited craving among female opioid-treated chronic pain patients. Development and Psychopathology 31:3, pages 1101-1110.
Crossref
Crossref
Silvia Natoli. (2019) Opioid use in addiction: swinging between pain under-treatment and opioids harms. Minerva Anestesiologica 85:8.
Crossref
Crossref
Ainhoa Coloma-Carmona, José L. Carballo, Jesús Rodríguez-Marín & Ana Pérez-Carbonell. (2019) Withdrawal symptoms predict prescription opioid dependence in chronic pain patients. Drug and Alcohol Dependence 195, pages 27-32.
Crossref
Crossref
Ana Miriam Velly & Shrisha Mohit. (2018) Epidemiology of pain and relation to psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 87, pages 159-167.
Crossref
Crossref
Ainhoa Coloma-Carmona, José-Luis Carballo, Jesús Rodríguez-Marín, Ana Pérez-Carbonell & Carlos Alonso-Garrido. (2018) Medical and psychological predictors of prescription opioids dependence during chronic pain treatment. European Review of Applied Psychology 68:6, pages 199-204.
Crossref
Crossref
Clara Pérez-Mañá, Esther Papaseit, Francina Fonseca, Adriana Farré, Marta Torrens & Magi Farré. (2018) Drug Interactions With New Synthetic Opioids. Frontiers in Pharmacology 9.
Crossref
Crossref
Mark D. Sullivan. (2018) Depression Effects on Long-term Prescription Opioid Use, Abuse, and Addiction. The Clinical Journal of Pain 34:9, pages 878-884.
Crossref
Crossref
Elizabeth L. Pestka & Michele Evans. (2018) Family history of substance use disorder and chronic pain management. The Nurse Practitioner 43:6, pages 43-48.
Crossref
Crossref
Gholam R. Kheirabadi, Mehrdad Salehi, Mahboobe Bahrami & Mohammad R. Maracy. (2018) Gabapentin, Pregabalin, and Placebo in Reducing Opioid Withdrawal Symptoms in Opioid-dependent Individuals: A Randomized-controlled Trial. Addictive Disorders & Their Treatment 17:2, pages 55-64.
Crossref
Crossref
Sidney H. Schnoll. (2018) Misconceptions and Realities of the Prescription Opioid Epidemic. Clinical Pharmacology & Therapeutics 103:6, pages 963-965.
Crossref
Crossref
Martin D Cheatle. (2018) Balancing the Risks and Benefits of Opioid Therapy for Patients with Chronic Nonmalignant Pain: Have We Gone Too Far or Not Far Enough?. Pain Medicine 19:4, pages 642-645.
Crossref
Crossref
Martin D Cheatle, Rollin M Gallagher & Charles P O’Brien. (2018) Low Risk of Producing an Opioid Use Disorder in Primary Care by Prescribing Opioids to Prescreened Patients with Chronic Noncancer Pain. Pain Medicine 19:4, pages 764-773.
Crossref
Crossref
J. Gregory Hobelmann & Michael R. Clark. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
419
426.e2
.
Martin D. Cheatle & Rollin M. Gallagher. 2018. Handbook of Pain and Palliative Care. Handbook of Pain and Palliative Care
475
505
.
Heath B. McAnallyHeath B. McAnally. 2018. Opioid Dependence. Opioid Dependence
233
264
.
Ahmed N. Hassan, Bernard Le Foll, Sameer Imtiaz & Jürgen Rehm. (2017) The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. Drug and Alcohol Dependence 179, pages 260-266.
Crossref
Crossref
Michael Von Korff, Rod L. Walker, Kathleen Saunders, Susan M. Shortreed, Manu Thakral, Michael Parchman, Ryan N. Hansen, Evette Ludman, Karen J. Sherman & Sascha Dublin. (2017) Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. International Journal of Drug Policy 46, pages 90-98.
Crossref
Crossref
Frank Anthony MyersJr.Jr., Martin H. Bluth & Wellman W. Cheung. (2016) Ketamine. Clinics in Laboratory Medicine 36:4, pages 721-744.
Crossref
Crossref
Brian T. Halbert, Roger B. Davis & Christina C. Wee. (2016) Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain 157:11, pages 2452-2457.
Crossref
Crossref
Kelly E. Dunn, Frederick S. Barrett, Michael Fingerhood & George E. Bigelow. (2016) Opioid Overdose History, Risk Behaviors, and Knowledge in Patients Taking Prescribed Opioids for Chronic Pain. Pain Medicine, pages pnw228.
Crossref
Crossref
Gabrielle Campbell, Raimondo Bruno, Nicholas Lintzeris, Milton Cohen, Suzanne Nielsen, Wayne Hall, Briony Larance, Richard P. Mattick, Fiona Blyth, Michael Farrell & Louisa Degenhardt. (2016) Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?. Pain 157:7, pages 1489-1498.
Crossref
Crossref
Hilary J. Mosher, Kelly K. Richardson & Brian C. Lund. (2016) The 1-Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Pain Medicine 17:7, pages 1282-1291.
Crossref
Crossref
W. Michael Hooten. (2016) Chronic Pain and Mental Health Disorders. Mayo Clinic Proceedings 91:7, pages 955-970.
Crossref
Crossref
Michael R. Von Korff & Gary Franklin. (2016) Responding to America’s Iatrogenic Epidemic of Prescription Opioid Addiction and Overdose. Medical Care 54:5, pages 426-429.
Crossref
Crossref